Clinical Trial Update: Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease [EARLY_Phase 1]

View source ↗

Summary

An investigator-initiated Phase 1 trial evaluating galcanezumab for Alzheimer's disease is currently recruiting in Beijing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Galcanezumab (galcanezumab)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Alzheimer Disease | EARLY_Phase 1 | Status: RECRUITING